Treatment of hemangiomas of infancy. Dermatol Ther 2005 Mar-Apr;18(2):151-9 PMID: 15953144
Pubmed ID
15953144Abstract
Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.
Author List
Barrio VR, Drolet BAAuthor
Beth A. Drolet MD Professor in the Dermatology department at Medical College of WisconsinScopus
2-s2.0-21644431713 19 CitationsMESH terms used to index this publication - Major topics in bold
HemangiomaHumans
Infant, Newborn
Neoplasms, Vascular Tissue
